Trial-Only Medicare Coverage Proposed For PET Alzheimer’s Scans

Beta amyloid positron emission tomography scans to help diagnose dementia would only be covered by Medicare as part of a clinical trial under a proposed national coverage decision. Eli Lilly requested broader coverage for its Amyvid PET imaging agent.

More from Policy & Regulation

More from Medtech Insight